Precision Genomic Medicine Conference

Precision Genomic Medicine Conference 2018

All of us strive to provide the best medical care we can.  By adding genetic data to our clinical armamentarium, we can refine our clinical examination, improve the care we deliver to our patients, and provide better and more targeted disease-specific treatment. This one-day conference targets health care professionals and provides an introduction to the integration of genomic data into routine patient management. We focus on the outstanding successes at the University of Iowa that are driving precision medicine, and highlight the benefits and the challenges associated with the routine the implementation of genetic data into standard practice.   

This conference is cosponsored by the Iowa Institute of Human Genetics, the UIHC Department of Pathology, the Holden Comprehensive Cancer Center, the Carver College of Medicine, illumina®, and Integrated DNA Technologies (IDT)

Venue: Medical Alumni Auditorium E331 GH; University of Iowa Hospitals and Clinics - 200 Hawkins Drive, Iowa City, IA 52242

Revised Schedule

Friday, April 27, 2018

8:00-8:30 Check-in (coffee and tea provided)  


J. Brooks Jackson, MD, MBA, VPMA and Dean of the Carver College of Medicine


Introduction: Precision Medicine and Genomic Data

What is Precision Medicine - Its Promises and Limitations - Richard Smith, MD, Director of the Iowa Institute of Human Genetics


Curing Heritable Blindness - Ed Stone, MD, PhD


Diagnostic Applications in Practice Today - Changing Diagnostic Algorithms

  • One Step Comprehensive Testing for Genetic Kidney Disease - Christie Thomas, MD
  • What I Have Learned Seeing Cardiovascular Genetic Patients Over Two Decades - Ferhaan Ahmad, MD, PhD
  • Changing approaches to genetic diagnosis in the Inherited neuropathies: Our experiences - Mike Shy, MD
  • Genetic Variant Classification: Implementing Disease-Specific Knowledge to Empower Clinical Decision-Making - Hela Azaiez, PhD
10:15-10:30 Break  

Precision Genomic Medicine at UIHC and in the Community

     Colleen Campbell

Keynote speaker: Pharmacogenomics: Precision Medicine and Drug Response

Richard Weinshilboum, MD - Mayo Clinic


Dr. Weinshilboum received B.A. and M.D. degrees from the University of Kansas, followed by residency training in Internal Medicine at the Massachusetts General Hospital in Boston.  He was also a Pharmacology Research Associate at the NIH in the laboratory of Nobel Laureate Dr. Julius Axelrod.  He is presently Professor of Pharmacology and Medicine and Dasburg Professor of Cancer Genomics Research at Mayo.  He also co-directs the Pharmacogenomics Program of the Mayo Center for Individualized Medicine.  Dr. Weinshilboum’s research has focused on pharmacogenomics, with over 425 manuscripts on that topic. His major area of research has been the pharmacogenetics of drug metabolism, with a focus on methylation and sulfation. He has also applied genome-wide “omics” to study drug response--especially the drug therapy of depression and breast cancer.  Dr. Weinshilboum has been the recipient of many awards including an Established Investigatorship of the American Heart Association, a Burroughs Wellcome Scholar Award in Clinical Pharmacology, the Oscar B. Hunter Award of the American Society for Clinical Pharmacology and Therapeutics, the ASPET Harry Gold Award and the Edvard Poulsson Award from the Norwegian Pharmacology Society.  He has also served on the Advisory Councils for two US NIH Institutes, the NIGMS and NHGRI.

11:45-12:00 Discussion  



Cancer Genomics in Diagnosis and Treatment

3:00-3:15 Break  
3:15-3:45 Ethics in Personalized Genomic Medicine - Anya Prince, JD

Panel Discussion - The Use of Smart Data in Precision Medicine

Mike Brownlee, PharmD, MS, FASHP; Timothy Gutshall, MD, Wellmark; Maia Hightower, MD, MBA, MPH; Anya Prince, JD

Panel Moderator:  Colleen Campbell, PhD, MS, CGC

                    Colleen Campbell, PhD, MS, CGC

Closing Remarks

Anne Kwitek, PhD

PDF iconPGM Conference Schedule Revised.pdf